Day: November 20, 2019

MINNEAPOLIS, Nov. 20, 2019 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 31st Annual Piper Jaffray Healthcare Conference on December 4, 2019 at the Lotte New York Palace Hotel in New York.Inspire is scheduled to present at 8:30 a.m. Eastern Time. The presentation will be accessible via a live webcast at: https://event.webcasts.com/starthere.jsp?ei=1270355&tp_key=b1d62da24aA webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.About...

SILICON SLOPES, Utah, Nov. 20, 2019 (GLOBE NEWSWIRE) — Domo (Nasdaq: DOMO) today announced it will showcase at AWS re:Invent 2019 how customers can quickly, easily and securely deliver business value from their Internet of Things (IoT) data while maximizing the value of their Amazon Web Services (AWS) investments.Domo will highlight the capabilities of its recently announced Domo for AWS solution, a purpose-built package that gives AWS customers an easy way to make data from nearly two dozen AWS services securely accessible to virtually anyone across the company. Domo will also showcase its IoT Cloud, which features one of the largest sets of pre-built API connectors for IoT data, including AWS IoT Analytics, AWS IoT Core, AWS IoT Device Defender, AWS IoT Device Management, and Amazon Kinesis Data Streams. Domo’s IoT Cloud also...

MIDVALE, Utah, Nov. 20, 2019 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s” or the “Company”) (Nasdaq: SPWH) today announced that it will hold its quarterly conference call to discuss third quarter fiscal 2019 financial results on Wednesday, December 4, 2019 at 4:30 p.m. Eastern Time. The conference call will be broadcast on the Company’s investor relations website at http://investors.sportsmans.com/.  An online archive of the webcast will be available for one year following the call.About Sportsman’s Warehouse Holdings, Inc.Sportsman’s Warehouse is an outdoor sporting goods retailer focused on meeting the everyday needs of the seasoned outdoor veteran, the first-time participant and every enthusiast in between. Our mission is to provide outstanding gear and...

NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (NASDAQ: PFLT) (TASE: PFLT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2019.CONFERENCE CALL AT 10:00 A.M. EST ON NOVEMBER 21, 2019PennantPark Floating Rate Capital Ltd. (“we,” “our,” “us” or the “Company”) will host a conference call at 10:00 a.m. (Eastern Standard Time) on Thursday, November 21, 2019 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing toll-free (800) 263-0877 approximately 5-10 minutes prior to the call. International callers should dial (646) 828-8143. All callers should reference conference ID #9659175 or PennantPark Floating Rate Capital Ltd. An archived replay of the call will be available through December...

DEERFIELD, Ill., Nov. 20, 2019 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced Camille Farhat, President and Chief Executive Officer, and Jonathon Singer, Chief Financial and Administrative Officer, are scheduled to present at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, at 11 a.m. EST in New York City.About RTI Surgical Holdings, Inc.RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic and trauma procedures and are distributed in nearly 50 countries. RTI has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in...

Nes Ziona, Israel, Nov. 20, 2019 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (“Enlivex” or the “Company”) (NASDAQ:ENLV) today announced that, subject to market and other conditions, it intends to offer and sell ordinary shares (the “Shares”) in an underwritten public offering. The Company intends to grant the underwriter an option for a period of 45 days to purchase up to an additional 15 percent of the number of Shares to be issued and sold in the public offering solely to cover over-allotments, if any.The Company intends to use the net proceeds received from the offering of the Shares for clinical, regulatory, manufacturing and research and development activities, potential acquisitions and in-licensing, and other general corporate purposes.Aegis Capital Corp. will act as sole book-runner for the offering.The offering of the...

MIDLAND, Texas, Nov. 20, 2019 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”) announced today that it has priced an offering of $1.0 billion of 2.875% senior notes that will mature on December 1, 2024 (“the 2024 notes”), $800 million of 3.250% senior notes that will mature on December 1, 2026 (“the 2026 notes”) and $1.2 billion of 3.500% senior notes that will mature on December 1, 2029 (“the 2029 notes” and, collectively with the 2024 notes and the 2026 notes, the “Notes”). The prices to the public for the 2024 notes, the 2026 notes and the 2029 notes are 99.959%, 99.858% and 99.741% of the principal amounts, respectively.Diamondback intends to use the net proceeds from the offering (i) to repay a portion of the outstanding borrowings under its revolving credit facility, (ii) to redeem all of the outstanding...

SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) — Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs. Using the patented Pfēnex Expression Technology platform, the Company has developed the FDA-approved PF708 product indicated for the treatment of osteoporosis in certain patients at high risk of fracture and created an advanced pipeline of therapeutic equivalents, biologics and vaccines. The Company announced today that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4th, taking place at the Lotte New York Palace in New York.Piper Jaffray 31st Annual Healthcare ConferenceDate:               ...

VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) — Colonial Coal International Corp. (TSX-V: CAD) (the “Corporation” or “Colonial Coal”) is pleased to announce that it has granted stock options (each, a “Stock Option”) to acquire an aggregate of up to 2,100,000 common shares of the Company to each of a certain director and consultant of the Company in accordance with the provisions of the Company’s previously approved share option plan. The Stock Options are fully vested and are exercisable at a price of $0.35 per common share for a period of 10 years from the date of grant.This grant of Options is subject to regulatory approval.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy...